| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $14.3M | +47.4% |
| SG&A Expense | $1.9M | +3951.2% |
| Operating Income | -$16.3M | — |
| Interest Expense | $42K | -77.9% |
| Net Income | -$17.1M | — |
| EPS (Basic) | -$3.30 | — |
| EPS (Diluted) | -$3.30 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.4M | — |
| Current Assets | $29.3M | — |
| Total Assets | $29.3M | — |
| Current Liabilities | $2.6M | +2375.1% |
| Total Liabilities | $5.5M | +5226.1% |
| Stockholders' Equity | $23.8M | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.0M | — |
| Financing Cash Flow | $39.7M | — |